Tejara Capital Ltd Makes New Investment in Orthofix Medical Inc. $OFIX

Tejara Capital Ltd purchased a new position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 58,720 shares of the medical device company’s stock, valued at approximately $537,000. Tejara Capital Ltd owned 0.15% of Orthofix Medical at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kestra Advisory Services LLC bought a new stake in shares of Orthofix Medical during the fourth quarter valued at about $56,000. CWM LLC boosted its position in Orthofix Medical by 136.4% during the 4th quarter. CWM LLC now owns 4,538 shares of the medical device company’s stock valued at $69,000 after buying an additional 2,618 shares during the period. Abel Hall LLC purchased a new stake in shares of Orthofix Medical in the 1st quarter worth about $139,000. Mackenzie Financial Corp purchased a new position in shares of Orthofix Medical during the 3rd quarter worth approximately $148,000. Finally, Strs Ohio bought a new stake in Orthofix Medical during the first quarter worth about $150,000. 89.76% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on OFIX. Canaccord Genuity Group reduced their price objective on shares of Orthofix Medical from $18.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, August 10th. TD Cowen reiterated a “hold” rating on shares of Orthofix Medical in a research note on Thursday, May 21st. Weiss Ratings reiterated a “sell (d-)” rating on shares of Orthofix Medical in a report on Friday, July 17th. Barrington Research raised their price target on shares of Orthofix Medical from $15.00 to $17.00 and gave the company an “outperform” rating in a research report on Monday, July 6th. Finally, Wall Street Zen lowered shares of Orthofix Medical from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $14.75.

Insider Activity at Orthofix Medical

In other news, insider Aviva Mcpherron sold 3,670 shares of the firm’s stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $9.38, for a total value of $34,424.60. Following the completion of the sale, the insider directly owned 66,330 shares of the company’s stock, valued at $622,175.40. This trade represents a 5.24% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 2.70% of the company’s stock.

Orthofix Medical Trading Down 4.5%

Shares of Orthofix Medical stock opened at $10.01 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.67 and a current ratio of 2.84. The company has a fifty day moving average of $10.61 and a 200 day moving average of $11.49. The company has a market capitalization of $407.71 million, a P/E ratio of -6.50 and a beta of 0.68. Orthofix Medical Inc. has a fifty-two week low of $8.85 and a fifty-two week high of $16.99.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings results on Wednesday, August 5th. The medical device company reported ($0.39) EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.02. The company had revenue of $210.93 million for the quarter, compared to analysts’ expectations of $209.28 million. Orthofix Medical had a negative return on equity of 14.05% and a negative net margin of 7.41%. On average, sell-side analysts anticipate that Orthofix Medical Inc. will post -1.29 earnings per share for the current fiscal year.

Orthofix Medical Profile

Orthofix Medical Inc (NASDAQ: OFIX) is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company’s core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.

Orthofix’s product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures.